SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:hb-32008"
 

Sökning: onr:"swepub:oai:DiVA.org:hb-32008" > Hospitalized patien...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007985naa a2200613 4500
001oai:DiVA.org:hb-32008
003SwePub
008240607s2024 | |||||||||||000 ||eng|
009oai:gup.ub.gu.se/337453
009oai:prod.swepub.kib.ki.se:238708065
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:hb:diva-320082 URI
0247 a https://doi.org/10.1016/j.resplu.2024.1006452 DOI
0247 a https://gup.ub.gu.se/publication/3374532 URI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:2387080652 URI
040 a (SwePub)hbd (SwePub)gud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Albert, Malinu Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden4 aut
2451 0a Hospitalized patients’ attitudes towards participating in a randomized control trial in case of a cardiac arrest
264 1c 2024
338 a electronic2 rdacarrier
520 a BackgroundNo previous study has evaluated patients attitudes towards inclusion in an ongoing cardiac arrest clinical trial. The aim of this study was to assess patientś willingness and motives to participate in the ongoing randomized controlled drug trial “Vasopressin and Steroids in addition to Adrenaline in cardiac arrest” (VAST-A trial) in case of an in-hospital cardiac arrest (IHCA).ObjectivesHospitalized patients, men ≥ 18 and women ≥ 50 years, were asked for informed consent for inclusion in the VAST-A trial in case of an IHCA, the reason for approving or declining inclusion in the trial and baseline characteristics.MethodsPatients admitted to hospital were asked to give informed consent of inclusion in VAST-A in case of an IHCA during their hospital stay. Patients were also asked why they approved or declined inclusion as well as baseline characteristics questions.Results1,064 patients were asked about willingness to participate in the VAST-A trial, of these 902 (84.8%) patients approved inclusion. A subgroup of 411 patients were, except willingness, also asked about motives to participate or not and basic characteristics. The main reason for approving inclusion was to contribute to research (n = 328, 83.9%). The main reason for declining inclusion was concerns regarding testing the drug treatment (n = 6, 30%).ConclusionAmong hospitalized patients the vast majority gave informed consent to inclusion in an ongoing randomized cardiac arrest drug trial. The main reason for approving inclusion was to contribute to research.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Omvårdnad0 (SwePub)303052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nursing0 (SwePub)303052 hsv//eng
653 a Informed consen
653 a tWaiver informed consent
653 a Cardiac arrest
653 a Människan i vården
653 a The Human Perspective in Care
653 a Cardiac arrest; Informed consent; Waiver informed consent.
7001 a Thonander, Marieu Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden4 aut
7001 a Forsberg, Suneu Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden4 aut
7001 a Lindgren, Fridau Norrtälje Hospital, Norrtälje, Sweden4 aut
7001 a Thuccani, Meenau Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden4 aut0 (Swepub:gu)xthume
7001 a Odell, Annika,d 1960u Gothenburg University,Göteborgs universitet,Institutionen för vårdvetenskap och hälsa,Institute of Health and Care Sciences,Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden; Institute of Health and Care Science at University of Gothenburg, Sweden4 aut0 (Swepub:gu)xodean
7001 a Skoglund, Kristofer,d 1976u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden4 aut0 (Swepub:gu)xskokr
7001 a Bergh, Niklas,d 1979u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden4 aut0 (Swepub:gu)xbergn
7001 a Hollenberg, Jacobu Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden4 aut
7001 a Ringh, Mattiasu Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden4 aut
7001 a Jonsson, Martinu Karolinska Institutet,Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden4 aut
7001 a Nordberg, Peru Karolinska Institutet,Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Sweden; Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, 17176 Stockholm, Sweden ; Department of Physiology and Pharmacology, Karolinska Institute, Sweden4 aut
7001 a Lundgren, Peteru Gothenburg University,Göteborgs universitet,Högskolan i Borås,Akademin för vård, arbetsliv och välfärd,Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Cardiology, Gothenburg, Sweden; Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, 17176 Stockholm, Sweden;,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xlpetj
7102 a Department of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Swedenb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org
7730 t Resuscitation Plusg 18q 18x 2666-5204
8564 u https://doi.org/10.1016/j.resplu.2024.100645y Fulltext
8564 u https://hb.diva-portal.org/smash/get/diva2:1866616/FULLTEXT01.pdfx primaryx Raw objecty fulltext:postprint
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:hb:diva-32008
8564 8u https://doi.org/10.1016/j.resplu.2024.100645
8564 8u https://gup.ub.gu.se/publication/337453
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:238708065

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy